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Abstract The effect of nitric oxide (NO) on osteoblastic 
differentiation was examined in cultured mouse osteoblasts. 
Interleukin-lp and tumor necrosis factor-a expressed inducible 
NO synthase gene with little effect on constitutive NO synthase 
gene. These cytokines increased NO production, which was 
inhibited by L - N M M A pretreatment, and decreased alkaline 
phosphatase (AlPase) activity, which was not restored by L-
NMMA. Furthermore, NO donors, sodium nitroprusside and 
NONOate dose-dependently elevated AlPase activity and 
expression of osteocalcin gene. These results suggest that N O 
directly facilitates osteoblastic differentiation and the cytokine-
induced inhibition of AlPase activity is mediated via mechanism 
other than N O . 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Nitric oxide (NO) is involved in various pathophysiological 
processes in many tissues [1] and is produced from L-arginine 
by nitric oxide synthase (NOS). So far, three isoforms of N O S 
are isolated. Two constitutive isozymes; endothelial cell (ec-
NOS) and neuronal (nNOS) types which produce less amount 
of N O with several physical/chemical stimuli, while inducible 
isoform (iNOS) yields larger amount of N O through de novo 
synthesis of the enzyme in response to proinflammatory cyto-
kines or bacterial endotoxin [1]. 
Osteoblasts have been reported to produce N O after induc-
tion of iNOS gene by cytokines [2,3], and N O may inhibit the 
bone-resorbing activity in adjacent osteoclasts [2,4], suggesting 
a cross-talk between osteoblast and osteoclast via N O . Never-
theless, the role of N O in osteoblasts is still obscure. The 
purpose of the present study was addressed to examine 
whether (1) mouse osteoblast expresses constitutive (endothe-
lial cell type) and/or inducible N O S gene, (2) these genes ac-
tually increase N O production and (3) N O actively affects the 
osteoblastic differentiation, with using four parameters, alka-
line phosphatase (AlPase) activity and c G M P levels in osteo-
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blasts, an expression of osteocalcin gene and PGE 2 synthesis 
in culture medium. 
2. Materials and methods 
2.1. Cell culture 
Primary cultures of mouse osteoblasts were prepared from 1-day-
old ddy mouse calvaria as described previously [5]. Isolated cells were 
grown in a MEM (Gibco, Grand Island, NY, USA) containing 10% 
fetal bovine serum (Bioserum, Victoria, Australia), penicillin, strepto-
mycin and amphotericin B (Sigma, St. Louis, MO, USA). When in-
dicated, NG-monomethyl-L-arginine ( L - N M M A , Wako, Osaka, Japan, 
10~'1 M) was applied to the culture medium 4 days before and 
throughout cytokine stimulation described below. 
2.2. Reverse transcription-polymerase chain reaction 
Each NOS message was detected using RT-PCR as described pre-
viously [6]. Total RNA was extracted, and the reverse transcribed 
cDNA was used as a template for PCR. The primer sequences for 
ecNOS were: upper, 5'-GGCATCACCAGGAAGAAGAC (1516-
1535); and lower, 5'-ACTGGACTCCTTCCTCTTCC (1953-1934) 
[6]. The primer sequences for iNOS were: upper, 5'-GGAAAAGGA-
CATTAACAACAA (244-264); and lower, 5'-ATGTACCAGC-
CATTGAAGGGG (1287-1267) [7], 
Diethylamine NONOate (Cayman Chemical, Ann Arbor, MI, 
USA) was applied to osteoblasts for 48 h and the total RNA was 
extracted and used for detection of osteocalcin message. The primer 
sequences for osteocalcin were: upper, 5'-ATGAGGACCCTCTC-
TCTGCT (49-69); and lower, 5'-CCGTAGATGCGTTTGTAGGC 
(325-305) [8]. 
The annealing/elongating/denaturating conditions for the PCR re-
action was 56/72/94°C for a total of 25 cycles, 55/72/94°C for a total 
of 30 cycles, 55/72/94°C for a total of 35 cycles with an initial 5 min 
denaturation and an additional 10 min (7 min for osteocalcin) exten-
sion step at 72°C for ecNOS, iNOS and osteocalcin, respectively. The 
reaction products were separated by gel electrophoresis and stained in 
ethidium bromide. 
2.3. Assays of nitrate/nitrite, cGMP, AlPase and prostaglandin E2 
(PGE2)' 
NO was measured as nitrate/nitrite products in medium 48 h after 
the incubation with or without recombinant tumor necrosis factor-a 
(TNF-a, 100 ng/ml, Dainippon Pharmaceutical, Tokyo, Japan) and/or 
interleukin-ip (IL-ip, 10 ng/ml, Genzyme, Cambridge, MA, USA). 
Nitrate was converted to nitrite with nitrate reductase, then Griess 
reagent was applied for spectrophotometric measurement at 540 nm 
[9]. Nitrite level was normalized with protein amount measured by 
Bradford's method (Bio-Rad, Germany). 
NO action was verified with measurement of cGMP with or without 
addition of an NO donor, sodium nitroprusside (SNP, Wako). For 
cGMP assay, confluent cells were preincubated at 37°C for 20 min 
then with 0.1 mM 3-isobutyl-l-methylxanthine (Wako) for 6 min. 
After 2 min of administration of SNP, incubation was terminated 
with ice-cold 10% trichloroacetic acid. cGMP levels were determined 
using a EIA kit (Cayman Chemical). 
In bone tissues, the expression of AlPase is closely associated with 
osteoblastic differentiation [10]. Osteoblasts applied SNP for 5 h or 
cytokines for 48 h were washed twice with phosphate-buffered saline 
and then lysed in 0.1% Triton X-100. An aliquot of homogenate after 
three cycles of freezing and thawing was assayed for AlPase activity 
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Fig. 1. Expression of iNOS, ecNOS and GAPDH mRNA in unstimulated cells or cells stimulated with several factors. Isolated mRNA was re-
verse transcribed and amplified by PCR. The PCR product showed the 526-bp and 1044-bp for ecNOS for iNOS of predicted size, respectively. 
Lanes: 1, DNA size markers; 2, unstimulated osteoblasts; 3, TNF-a-treated cells; 4, IL-lB-treated cells; 5, TNF-a plus IL-lB-treated cells. 
(Wako, Osaka). The content of PGE2 in culture media of the osteo-
blasts were measured using a EIA kit (Cayman Chemical). 
2.4. Statistics 
All values were expressed as the mean±SE. Statistical differences 
between the values were examined by one-way ANOVA for multiple 
comparisons followed by Fisher's test. The p values less than 0.05 
were considered significant. 
3. Results 
3.1. Induction of mRNA of iNOS and ecNOS by cytokines 
We used RT-PCR to define the isoforms of NOS specifi-
cally expressed in mouse osteoblasts (Fig. 1). iNOS mRNA 
was not detected in unstimulated cells or cells treated with 
TNF-a (100 ng/ml) alone. In contrast, IL-lp (10 ng/ml) and 
combinations of two cytokines (TNF-a+IL-P) induced the 
iNOS mRNA expression (a 1044-bp PCR product in Fig. 
1). In contrast, ecNOS mRNA was detected in both unstimu-
lated and stimulated osteoblasts (a 526-bp PCR product in 
Fig. 1). These data suggest that iNOS gene was exclusively 
induced by IL-lp, but not by TNF-a alone, while ecNOS gene 
was constitutively expressed, irrespective of the stimulation 
with these cytokines. 
3.2. Modulation of NO production and AlPase activity with 
cytokines 
Without cytokine, mouse osteoblasts released a modest but 
steady amount of NO detected as nitrate/nitrite (25.7 ± 5.5 
nmol/mg protein, Fig. 2). TNF-a (100 ng/ml) alone had no 
effect on the basal release (25.0 ± 5.0 nmol/mg protein). In 
contrast, IL-ip (10 ng/ml) increased the NO production to 
46.6 ±5.3 nmol/mg protein (p<0.02, vs. control). Combina-
tion of TNF-a and IL-lp enhanced the NO production three 
folds over the control level (70.7 ±7.2 nmol/mg protein, 
p<0.0001, vs. control), indicating that IL-ip synergistically 
increased NO production with TNF-a via NOS induction. 
The increased NO production by combination of TNF-a 
plus IL-ip was attenuated by a competitive NOS inhibitor, 
L - N M M A (10~4 M, Fig. 3A), and decreased from 75.9 ±2.6 
nmol/mg protein to 36.1 ±2.6 nmol/mg protein (p<0.05, vs. 
TNF-a+IL-ip). 
Combination of TNF-a and IL-ip reduced AlPase activity 
in osteoblasts (77.4 ± 4.6 vs. 56.6 ± 2.7 nmol/min per mg pro-
tein). These results are compatible with the previous reports 
that TNF-a and/or IL-lp possess bone-resorbing action 
[11,12]. However, L - N M M A did not restore the reduced level 
of AlPase by these cytokines at all (54.9 ± 2.6 nmol/min per 
mg protein, Fig. 3B). These results indicate that the bone-
resorbing effect of cytokines is not mediated via NO, despite 
of cytokine induction of iNOS gene and the actual NO pro-
duction. 
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Fig. 2. Stimulatory effects of TNF-a and IL-1B on NO production, 
measured as nitrate/nitrite in osteoblasts (mean ± SE, n = 12). * indi-
cates a significant difference (p<0.02), compared with the control 
(Ctl). 
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Fig. 3. Inhibitory effect of L-NMMA on NO production (A) and al-
kaline phosphatase (AIP) activity in culture medium (B). * and # 
indicate a significant difference (p< 0.001), compared with the con-
trol and condition stimulated by TNF-a plus IL-ip, respectively. 
Each value denotes the mean ± SE (n = 6). 
Fig. 4. Effects of SNP on cGMP levels (mean ± SE, n = 5) (A), alka-
line phosphatase (AIP) activity (mean±SE, «=10) (B), and PGE2 
production (mean±SE, « = 5) (C) in osteoblasts. * denotes a signifi-
cant difference (/? < 0.001), compared with the control. 
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Fig. 5. Expression of osteocalcin and GAPDh mRNA in unstimulated cells or cells stimulated with diethylamine NONOate. Isolated mRNA 
was reverse transcribed and amplified by PCR. The PCR product was 276 bp. Lanes: 1, DNA size markers; 2, unstimulated osteoblasts; 3, 0.1 
nM diethylamine NONOate-treated cells; 4, 100 nM diethylamine NONOate-treated cells. 
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3.3. Effect of NO donors on biosynthesis of cGMP, AlPase 
activity and PGE2 production, and osteocalcin gene 
expression 
To examine the direct effect of NO on osteoblasts, we used 
the NO donor, SNP or diethylamine NONOate [13]. Two-
minute incubation of SNP ( > 10~4 M) increased intracellular 
cGMP level in concentration-dependent manner (Fig. 4A). 
This result confirms our previous report that NO has an au-
tocrine action on the NO producing cells themselves, as well 
as adjacent cells via paracrine action [14,15]. 
Osteoblasts treated with SNP for 5 h, did elevate AlPase 
activity in a concentration-dependent manner (Fig. 4B), ex-
hibiting a clear contrast with the reduction of the activity in 
cytokine-stimulated osteoblasts (Fig. 3B). In response to SNP, 
the level of PGE2 in culture medium decreased in a concen-
tration-dependent manner (Fig. 4C). The SNP concentrations 
necessary for 50% increment for cGMP synthesis and AlPase 
activity were 10~4 M and 10~8 M, respectively. 
The expression of osteocalcin mRNA was enhanced in os-
teoblasts when they were treated by a long-lasting NO donor, 
diethylamine NONOate, for 48 h more than untreated osteo-
blasts (a 276-bp PCR product in Fig. 5). 
4. Discussion 
Rat osteosarcoma cells have been reported to express nNOS 
[16]. However, the expression of ecNOS in osteoblasts have 
not been reported thus far. We have found that mouse osteo-
blasts express ecNOS gene constitutively and iNOS gene only 
after cytokine stimulation. We have also found ecNOS and 
iNOS in human osteosarcoma cells (data not shown). Fur-
thermore, homogeneous staining was observed in mouse-os-
teoblast culture with specific antibody against ecNOS (data 
not shown). These results show that ecNOS expresses in 
mouse osteoblasts at both mRNA and protein level. The cy-
tokine-induced NO production was inhibited by L - N M M A . 
These cytokines also decreased osteoblastic differentiation in 
terms of reduction of AlPase activity without restoration by 
L - N M M A . Present results were totally different from the pre-
vious report by Hukkanen et al. [3] in the aspect of L-NMMA 
action on cytokine-induced AlPase activity and accordingly 
give rise to an argument against the scheme that NO facili-
tates osteoblastic differentiation. 
The role of steady ecNOS gene expression and low but 
significant concentrations of NO produced in unstimulated 
cells (Fig. 2) has not been noticed so far. Low concentrations 
of NO produced by ecNOS may control the basal metabolism 
of osteoblasts. In addition to the basal synthesis of NO by 
ecNOS, large amount of NO may have been produced by 
iNOS after the induction by IL-lfi and TNF-oc+IL-ip (Figs. 
2 and 3A). This situation will take place in the setting of 
inflammatory response of osteoblastic metabolism. 
iNOS is not an only gene induced by IL-lp and/or TNF-a 
in osteoblasts. IL-1(3 induces cyclic AMP production in hu-
man osteoblasts [17]. TNF-a also promotes the expression of 
prostaglandin endoperoxide synthase-2 mRNA and synthesis 
of PGE2 [18]. In other tissues, such as vascular tissues, the 
condition which evokes NO simultaneously produces super-
oxide anion (02~) to form peroxynitrite (ONOO~) [19]. There 
is no evidence that the cytokine-induced NO has direct action 
on bone resorption. 
Accordingly, it is of a great significance to know the direct 
effect of NO on osteoblasts. An NO donor, SNP, increased 
the AlPase activity, which is the index of osteoblastic differ-
entiation, in a concentration-dependent manner. It also in-
creased the intracellular concentration of cGMP, which is 
the second messenger of NO as well as the activator of the 
osteoblastic differentiation [20,21]. The long-lasting NO do-
nor, diethylamine NONOate, increased the gene expression 
of osteocalcin, which is the another index of osteoblastic dif-
ferentiation [22,23]. On the contrary, it decreased the levels of 
PGE2 in medium. Prostaglandins are multifunctional regula-
tors with stimulatory and inhibitory effects on bone metabo-
lism [24]. At low concentrations, PGE2 increased collagen syn-
thesis in cultured fetal rat calvaria, whereas at high 
concentrations, the major effect was inhibitory. However, as 
to the osteoblastic differentiation, PGE2 is reported to be in-
hibitory [25]. Present findings indicate that NO acts on osteo-
blastic differentiation and suggest that NO inhibits bone re-
sorption through PGE2 production by osteoblasts. 
SNP below 10~4 M changed the levels of both AlPase ac-
tivity and PGE2 in medium, while the same agent above 10
- 4 
M raised the intracellular concentration of cGMP, the second 
messenger of NO. These results suggest that the effect of NO 
on osteoblastic differentiation is mediated by both cGMP-de-
pendent and independent mechanisms. Actually, NO action is 
not simply cGMP-dependent, and cGMP-independent path-
way also plays significant role on platelets, fibroblasts and 
osteoclasts [4,26,27]. 
In conclusion, we have demonstrated that NO directly 
facilitates osteoblastic differentiation and that it is not re-
sponsible for the action of cytokine-induced bone resorption. 
We have also shown evidence that osteoblasts have ecNOS 
which may control the basal level of osteoblastic differentia-
tion. 
Acknowledgements: The authors appreciate Dr. K. Hosoi (Depart-
ment of Gerontology, University of Tokyo) for kind advice to pri-
mary murine osteoblast culture and Dr. Y. Nunokawa (Suntory In-
stitute for Biomedical Research) for designing of inducible NOS 
primer. A part of this work was financially supported by a grant 
from Grant-in-Aid for Scientific Research (No. 07557082) from the 
Ministry of Education, Science and Culture of Japan; the Ministry of 
Health and Welfare; the Fugaku Trust; Study group of Molecular 
Cardiology; and the Mochida Memorial Foundation for Medical and 
Pharmacological Research. 
References 
[1] Moncada, S., Palmer, R.M.J., Hibbs, J.R. and Higgs, E.A. (1991) 
Pharmacol. Rev. 43, 109-142. 
[2] Lowik, C.W.G.M., Nibbering, P.H., van de Ruit, M. and Papa-
poulos, S.E. (1994) J. Clin. Invest. 93, 1465-1472. 
[3] Hukkanen, M., Hughes, F.J., Buttery, L.D.K., Gross, S.S., 
Evans, T.J., Seddon, S., Riveros-Moreno, V., Macintyre, I. and 
Polak, J.M. (1995) Endocrinology 136, 5445-5453. 
[4] Macintyre, I., Zaidi, M., Towhidul Alam, A.S.M., Datta, H.K., 
Moonga, B.S., Lidbury, P.S., Hecker, M. and Vane, J.R. (1991) 
Proc. Natl. Acad. Sci. USA 88, 2936-2940. 
[5] Takahashi, N., Akatsu, T., Udagawa, N., Sasaki, T., Yamaguchi, 
A., Moseley, J.M., Martin, T.J. and Suda, T. (1988) Endocrinol-
ogy 123, 2600-2602. 
[6] Liao, J.K., Shin, W.S., Lee, W.Y. and Clark, S.L. (1995) J. Biol. 
Chem. 270, 319-324. 
[7] Lyons, C.R., Orloff, G.J. and Cunningham, J.M. (1992) J. Biol. 
Chem. 267, 6370-6374. 
[8] Celeste, A.J., Rosen, V., Buecker, J.L., Kriz, R., Wang, E.A. and 
Wozney, J.M. (1986) EMBO J. 5, 1885-1890. 
[9] Green, L.C., Wagner, D.A., Glogowski, J., Skipper, P.L., Wish-
242 H. Hikiji et al.lFEBS Letters 410 (1997) 238-242 
nok, J.S. and Tannenbaum, S.R. (1982) Anal. Biochem. 126, 
131-138. 
[10] Noda, M., Yoon, K., Thiede, M., Buenaga, R., Weiss, M., Hen-
thorn, P., Harris, H. and Rodan, G.A. (1987) J. Bone Miner. 
Res. 2, 161-164. 
[11] Gowen, M., Wood, D.D., Ihrie, E.J., McGuire, M.K.B. and 
Russell, R.G.G. (1983) Nature 306, 378-380. 
[12] Bertolini, D.R., Nedwin, G.E., Bringman, T.S., Smith, D.D. and 
Mundy, G.R. (1986) Nature 319, 516-518. 
[13] Maragos, CM., Morley, D., Wink, D.A., Dunams, T.M., Saave-
dra, J.E., Hoffman, A., Bove, A.A., Isaac, L., Hrabie, J.A. and 
Keefer, L.K. (1991) J. Med. Chem. 34, 3242-3247. 
[14] Shin, W.S., Sasaki, T., Kato, M., Hara, K., Seko, A., Yang, W., 
Shimamoto, N., Sugimoto, T. and Toyo-oka, T. (1992) J. Biol. 
Chem. 267, 20377-20382. 
[15] Wang, Y.P., Shin, W.S., Kawaguchi, H., Inukai, M., Kato, M., 
Sakamoto, A., Uehara, Y., Miyamoto, M., Shimamoto, N., Ko-
renaga, R., Ando, J. and Toyo-oka, T. (1996) J. Biol. Chem. 271, 
5647-5655. 
[16] Riancho, J.A., Salas, E., Zarrabeitia, M.T., Olmos, J.M., Ama-
do, J.A., Fernandez-Luna, J.L. and Gonzalez-Macias, J. (1995) 
J. Bone Miner. Res. 10, 439^146. 
[17] Bornefalk, E., Ljunghall, S., Johansson, A.G., Nilsson, K. and 
Ljunggren, 6 . (1994) Bone Miner. 27, 97-107. 
[18] Brum-Fernandes, A.J., Laporte, S., Heroux, M., Lora, M., Patry, 
C , Menard, H.A., Dumais, R. and Leduc, R. (1994) Biochem. 
Biophys. Res. Commun. 198, 955-960. 
[19] Beckman, J.S., Beckman, T.W., Chen, J., Marshall, P.A. and 
Freeman, B.A. (1990) Proc. Natl. Acad. Sci. USA 87, 1620-1624. 
[20] Inoue, A., Hiruma, Y., Hirose, S., Yamaguchi, A. and Hagiwara, 
H. (1995) Biochem. Biophys. Res. Commun. 215, 1104-1110. 
[21] Hagiwara, H., Inoue, A., Yamaguchi, A., Yokose, S., Furuya, 
M., Tanaka, S. and Hirose, S. (1996) Am. J. Physiol. 270, 
C1311-C1318. 
[22] Gary, S.S., Lian, J.B. (1993) in: Cellular and Molecular Biology 
of Bone (Noda, M., Ed.), pp. 47-95, Academic Press, New York, 
NY. 
[23] Lian, J., Stewart, C , Puchacz, E., Mackowiak, S., Shalhoub, V., 
Collart, D., Zambetti, G. and Stein, G. (1989) Proc. Natl. Acad. 
Sci. USA 86, 1143-1147. 
[24] Kawaguchi, H., Pilbeam, C.C., Harrison, J.R. and Raisz, L.G. 
(1995) Clin. Orthop. 313, 36-46. 
[25] Ozawa, H., Imamura, K., Abe, E., Takahashi, N., Hiraide, T., 
Shibasaki, Y., Fukuhara, T. and Suda, T. (1990) J. Cell. Physiol. 
142, 177-185. 
[26] Brline, B. and Lapetina, E.G. (1989) J. Biol. Chem. 264, 8455-
8458. 
[27] Garg, U.C. and Hassid, A. (1991) J. Biol. Chem. 266, 9-12. 
